Literature DB >> 21356259

Insulin resistance and liver microcirculation in a rat model of early NAFLD.

Marcos Pasarín1, Juan G Abraldes, Aina Rodríguez-Vilarrupla, Vincenzo La Mura, Joan Carles García-Pagán, Jaime Bosch.   

Abstract

BACKGROUND & AIMS: Insulin contributes to vascular homeostasis in peripheral circulation, but the effects of insulin in liver microvasculature have never been explored. The aim of this study was to assess the vascular effects of insulin in the healthy and fatty liver.
METHODS: Wistar rats were fed a control or a high fat diet (HFD) for 3days, while treated with a placebo, the insulin-sensitizer metformin, or the iNOS inhibitor 1400W. Vascular responses to insulin were evaluated in the isolated liver perfusion model. Insulin sensitivity at the sinusoidal endothelium was tested by endothelium-dependent vasodilation in response to acetylcholine in the presence or absence of insulin and by the level of liver P-eNOS after an insulin injection.
RESULTS: Rats from the HFD groups developed liver steatosis. Livers from the control group showed a dose-dependent hepatic vasodilation in response to insulin, which was blunted in livers from HFD groups. Metformin restored liver vascular insulin-sensitivity. Pre-treatment with insulin enhanced endothelium-dependent vasodilation of the hepatic vasculature and induced hepatic eNOS phosphorylation in control rats but not in HFD rats. Treatment with metformin or 1400W restored the capacity of insulin to enhance endothelium dependent vasodilation and insulin induced eNOS phosphorylation in HFD rats.
CONCLUSIONS: The administration of a HFD induces insulin resistance in the liver sinusoidal endothelium, which is mediated, at least in part, through iNOS upregulation and can be prevented by the administration of metformin. Insulin resistance at the hepatic vasculature can be detected earlier than inflammation or any other sign of advanced NALFD.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356259     DOI: 10.1016/j.jhep.2011.01.053

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  27 in total

1.  eNOS deletion impairs mitochondrial quality control and exacerbates Western diet-induced NASH.

Authors:  Ryan D Sheldon; Grace M Meers; E Matthew Morris; Melissa A Linden; Rory P Cunningham; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-30       Impact factor: 4.310

2.  Contrast-Based Real-Time Assessment of Microcirculatory Changes in a Fatty Liver After Ischemia Reperfusion Injury.

Authors:  Vasantha L Kolachala; Rong Jiang; Carlos R Abramowsky; Nitika A Gupta
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-03       Impact factor: 2.839

Review 3.  The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease.

Authors:  Sven M Francque
Journal:  Eur Cardiol       Date:  2014-07

Review 4.  Nitric oxide in liver diseases.

Authors:  Yasuko Iwakiri; Moon Young Kim
Journal:  Trends Pharmacol Sci       Date:  2015-05-28       Impact factor: 14.819

5.  Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease.

Authors:  S Lefere; F Van de Velde; L Devisscher; M Bekaert; S Raevens; X Verhelst; Y Van Nieuwenhove; M Praet; A Hoorens; C Van Steenkiste; H Van Vlierberghe; B Lapauw; A Geerts
Journal:  Int J Obes (Lond)       Date:  2017-05-02       Impact factor: 5.095

Review 6.  Role of liver sinusoidal endothelial cells in liver diseases.

Authors:  Jordi Gracia-Sancho; Esther Caparrós; Anabel Fernández-Iglesias; Rubén Francés
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-15       Impact factor: 46.802

7.  Chronic NOS inhibition accelerates NAFLD progression in an obese rat model.

Authors:  Ryan D Sheldon; Jaume Padilla; Nathan T Jenkins; M Harold Laughlin; R Scott Rector
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-08       Impact factor: 4.052

8.  Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats.

Authors:  Ryan D Sheldon; M Harold Laughlin; R Scott Rector
Journal:  J Appl Physiol (1985)       Date:  2014-02-27

Review 9.  Prevention of portal hypertension: from variceal development to clinical decompensation.

Authors:  Julio D Vorobioff; Roberto J Groszmann
Journal:  Hepatology       Date:  2014-09-26       Impact factor: 17.425

10.  Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?

Authors:  Ryuta Shigefuku; Hideaki Takahashi; Minoru Kobayashi; Hiroki Ikeda; Kotaro Matsunaga; Chiaki Okuse; Nobuyuki Matsumoto; Shiro Maeyama; Shigeru Sase; Michihiro Suzuki; Fumio Itoh
Journal:  J Gastroenterol       Date:  2012-05-11       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.